Clinical Trial Update: SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the combination of stereotactic body radiotherapy (SBRT) with a PD-1 monoclonal antibody for unresectable colorectal liver met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• PD-1 monoclonal antibody

Snippet

Sponsor: Jun Huang | Conditions: Colorectal Cancer, Liver Metastases | Phase 3 | Status: RECRUITING